RTNXF (Renalytix) Net Margin % : -905.75% (As of Sep. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Renalytix Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Renalytix's Net Income for the three months ended in Sep. 2024 was $-4.73 Mil. Renalytix's Revenue for the three months ended in Sep. 2024 was $0.52 Mil. Therefore, Renalytix's net margin for the quarter that ended in Sep. 2024 was -905.75%.

The historical rank and industry rank for Renalytix's Net Margin % or its related term are showing as below:

RTNXF' s Net Margin % Range Over the Past 10 Years
Min: -2079.96 Med: -1492.96 Max: -1221.67
Current: -1221.67

RTNXF's Net Margin % is ranked worse than
97.14% of 664 companies
in the Healthcare Providers & Services industry
Industry Median: 1.895 vs RTNXF: -1221.67

Renalytix Net Margin % Historical Data

The historical data trend for Renalytix's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renalytix Net Margin % Chart

Renalytix Annual Data

Trend

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Net Margin %

Get a 7-Day Free Trial

-2,079.81

-1,524.44

-1,340.20

-1,461.60

Renalytix Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Net Margin %	Get a 7-Day Free Trial															-2,212.20	-1,288.01	-1,447.29	-1,207.17	-905.75

Competitive Comparison of Renalytix's Net Margin %

For the Health Information Services subindustry, Renalytix's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Renalytix's Net Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Renalytix's Net Margin % distribution charts can be found below:

* The bar in red indicates where Renalytix's Net Margin % falls into.

Renalytix Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Renalytix's Net Margin for the fiscal year that ended in Jun. 2024 is calculated as

Net Margin	=	Net Income (A: Jun. 2024 )	/	Revenue (A: Jun. 2024 )
	=	-33.456	/	2.289
	=	-1,461.60 %

Renalytix's Net Margin for the quarter that ended in Sep. 2024 is calculated as

Net Margin	=	Net Income (Q: Sep. 2024 )	/	Revenue (Q: Sep. 2024 )
	=	-4.728	/	0.522
	=	-905.75 %

Renalytix (OTCPK:RTNXF) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Renalytix Net Margin % Related Terms

Thank you for viewing the detailed overview of Renalytix's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Renalytix Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Renalytix PLC (OTCPK:RTNXF) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

RNLXY:USA RENX:UK 2O9A:Germany

Address

2 Leman Street, London, GBR, E1W 9US

Website

https://www.renalytix.com

Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the common and costly chronic medical conditions globally. The company's product is KidneyIntelX which is being designed to make improvements in kidney disease diagnosis and prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.